Non-depolarizing neuromuscular blocking agent

This page covers all Non-depolarizing neuromuscular blocking agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nicotinic acetylcholine receptor, Nicotinic acetylcholine receptor (neuromuscular junction), Nicotinic acetylcholine receptor (motor endplate).

Targets

Nicotinic acetylcholine receptor · Nicotinic acetylcholine receptor (neuromuscular junction) · Nicotinic acetylcholine receptor (motor endplate)

Marketed (6)

• Atracurium, TBW · St. Antonius Hospital · Anesthesia
  Atracurium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the neuromuscular junction to produce muscle paralysis.
• NIMBEX · Assistance Publique Hopitaux De Marseille · Anesthesia
  Nimbex (cisatracurium) is a non-depolarizing neuromuscular blocking agent that competitively inhibits acetylcholine at the neuromuscular junction.
• sufficient dose of rocuronium · Korea University Guro Hospital · Anesthesia
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the nicotinic acetylcholine receptor on the motor endplate, causing muscle paralysis.
• Muscle Relaxant (Rocuronium) · Ostfold Hospital Trust · Anesthesiology
  Rocuronium blocks acetylcholine receptors at the neuromuscular junction, preventing muscle contraction and causing paralysis.
• Rocuronium Injectable Solution · Federal University of São Paulo · Anesthesia
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the nicotinic acetylcholine receptor on the motor endplate, causing muscle paralysis.
• Curare (Atracurium) · CHU de Reims · Anesthesia
  Atracurium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the neuromuscular junction, causing paralysis.

Phase 3 pipeline (8)

• Rocuronium bromide (Org 9426) · Merck Sharp & Dohme LLC · Anesthesiology
  Rocuronium bromide is a non-depolarizing neuromuscular blocking agent that competitively inhibits the nicotinic acetylcholine receptor at the neuromuscular junction.
• Rocuronium 1.2 · Ain Shams University · Anesthesiology
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the nicotinic acetylcholine receptor on the motor endplate.
• Rocuronium elective surgery · Diskapi Yildirim Beyazit Education and Research Hospital · Anesthesiology
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the nicotinic acetylcholine receptor on the motor endplate.
• Continuous rocuronium infusion · University Hospital, Antwerp · Anesthesia / Critical Care
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively antagonizes acetylcholine at the nicotinic acetylcholine receptor on the motor endplate, causing muscle paralysis.
• Repeated rocuronium dose · University Hospital, Antwerp · Anesthesiology
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively inhibits the nicotinic acetylcholine receptor at the neuromuscular junction.
• Rocuronium 0.8 · Ain Shams University · Anesthesiology
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively inhibits nicotinic acetylcholine receptors at the neuromuscular junction.
• Single rocuronium dose · University Hospital, Antwerp · Anesthesiology
  Rocuronium is a non-depolarizing neuromuscular blocking agent that competitively inhibits the nicotinic acetylcholine receptor at the neuromuscular junction.
• Rocuronium bromide (Zemuron) · Merck Sharp & Dohme LLC · Anesthesiology
  Rocuronium bromide is a non-depolarizing neuromuscular blocking agent that competitively inhibits the nicotinic acetylcholine receptor at the neuromuscular junction.